IDL Biotech AB share has been listed on Spotlight Stock Market since (26/6 2000) under the ticker (IDL B) and is traded through banks and stockbrokers.
In accordance with all regulations, IDL issues quarterly reports to the market and distributes the annual report to all shareholders. All this information is in Swedish.
The share holder’s annual meeting is usually held in Stockholm, and is announced accordingly.
2020-02-20 IDL Biotech fourth quarter report and Year-end report 2019
Ombokning av engångsintäkt
I samband med revisionen av räkenskapsåret 2019 har IDL ombokat den engångsintäkt bolaget erhöll i samband med byte av distributör i Indonesien från nettoomsättning till övrig rörelseintäkt.
IDL Biotech signs distributor agreement in Zimbabwe
IDL Biotech continues to expand in Africa. IDL Biotech has signed a distributor agreement with PHM Diagnostic Lab Ltd in Zimbabwe.
Registration of TUBEX TF approved in Indonesia
The registration of TUBEX TF has been approved in Indonesia.
Distribution agreement signed in Malaysia
IDL has signed a distribution agreement in Malaysia